Myocardial Infarction in Young Adults

Overview

Journal Postgrad Med J

Publisher Oxford University Press

Specialty General Medicine

Date 2005 Dec 14

PMID 16344295

Citations 70

Authors

M Egred

G Viswanathan

G K Davis

Affiliations

Soon will be listed here.

Abstract

Although myocardial infarction (MI) mainly occurs in patients older than 45, young men or women can suffer MI. Fortunately, its incidence is not common in patients younger than 45 years. However, the disease carries a significant morbidity, psychological effects, and financial constraints for the person and the family when it occurs at a young age. The causes of MI among patients aged less than 45 can be divided into four groups: (1) atheromatous coronary artery disease; (2) non-atheromatous coronary artery disease; (2) hyper-coagulable states; (4) MI related to substance misuse. There is a considerable overlap between all the groups. This article reviews the literature and highlights the practical issues involved in the management of young adults with MI.

Citing Articles

Influence of Clinical, Angiographic, and Developmental Characteristics and COVID-19 Severity and Vaccination Status on Young Patients with Acute Myocardial Infarction.

Vityala Y, Palagudi M, Para S, Meduri K, Duvvuri S, Manne L J Midlife Health. 2024; 15(3):173-181.

PMID: 39610960 PMC: 11601926. DOI: 10.4103/jmh.jmh_59_24.

Identifying risk factors and mortality rate of premature coronary artery disease in young Saudi population.

Al-Khlaiwi T, Habib S, Bayoumy N, Al-Khliwi H, Meo S Sci Rep. 2024; 14(1):12727.

PMID: 38830947 PMC: 11148092. DOI: 10.1038/s41598-024-62970-8.

Acute coronary syndrome patterns in the Young: risk factor profile and in-hospital outcomes in a tertiary referral hospital in Kenya.

Kassam N, Ngunga M, Varwani M, Msunza M, Jeilan M BMC Cardiovasc Disord. 2024; 24(1):192.

PMID: 38570757 PMC: 10988889. DOI: 10.1186/s12872-024-03832-z.

Acute Myocardial Infarction as the First Presentation of Systemic Lupus Erythematosus in a 23-Year-Old Patient.

Ayyad M, Albandak M, Khaleel M, Khalil N, Itmaizeh M Cureus. 2023; 15(6):e41026.

PMID: 37519572 PMC: 10373106. DOI: 10.7759/cureus.41026.

An In-Depth Prospective Comprehensive View on Myocardial Infarction (MI) in Young Adults.

Topalkatti U, Chennamalla M, N R, B P, Banothu R Cureus. 2023; 15(6):e40630.

PMID: 37485181 PMC: 10356967. DOI: 10.7759/cureus.40630.

References

Foody J, Milberg J, Robinson K, Pearce G, Jacobsen D, Sprecher D . Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol. 2000; 20(2):493-9. DOI: 10.1161/01.atv.20.2.493. View

Chouhan L, Hajar H, Pomposiello J . Comparison of thrombolytic therapy for acute myocardial infarction in patients aged < 35 and > 55 years. Am J Cardiol. 1993; 71(2):157-9. DOI: 10.1016/0002-9149(93)90731-q. View

MCGILL Jr H, McMahan C, Zieske A, Tracy R, Malcom G, Herderick E . Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. Circulation. 2000; 102(4):374-9. DOI: 10.1161/01.cir.102.4.374. View

Gaeta G, De Michele M, Cuomo S, Guarini P, Foglia M, Bond M . Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med. 2000; 343(12):840-6. DOI: 10.1056/NEJM200009213431203. View

Feron O, Dessy C, Desager J, Balligand J . Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation. 2001; 103(1):113-8. DOI: 10.1161/01.cir.103.1.113. View

Lange R, Hillis L . Cardiovascular complications of cocaine use. N Engl J Med. 2001; 345(5):351-8. DOI: 10.1056/NEJM200108023450507. View

Ghuran A, van der Wieken L, Nolan J . Cardiovascular complications of recreational drugs. BMJ. 2001; 323(7311):464-6. PMC: 1121066. DOI: 10.1136/bmj.323.7311.464. View

Isser H, Puri V, Narain V, Saran R, Dwivedi S, Singh S . Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives. Indian Heart J. 2002; 53(4):463-6. View

Osula S, Bell G, Hornung R . Acute myocardial infarction in young adults: causes and management. Postgrad Med J. 2002; 78(915):27-30. PMC: 1742222. DOI: 10.1136/pmj.78.915.27. View

10.

Sinha R, Fisch G, Teague B, Tamborlane W, Banyas B, Allen K . Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002; 346(11):802-10. DOI: 10.1056/NEJMoa012578. View

11.

Ebbeling C, Pawlak D, Ludwig D . Childhood obesity: public-health crisis, common sense cure. Lancet. 2002; 360(9331):473-82. DOI: 10.1016/S0140-6736(02)09678-2. View

12.

Mohlenkamp S, Hort W, Ge J, Erbel R . Update on myocardial bridging. Circulation. 2002; 106(20):2616-22. DOI: 10.1161/01.cir.0000038420.14867.7a. View

13.

Gowda R, Khan I, Vasavada B, Sacchi T . Alcohol-triggered acute myocardial infarction. Am J Ther. 2003; 10(1):71-2. DOI: 10.1097/00045391-200301000-00016. View

14.

Cole J, Miller 3rd J, Sperling L, Weintraub W . Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol. 2003; 41(4):521-8. DOI: 10.1016/s0735-1097(02)02862-0. View

15.

Klein L, Nathan S . Coronary artery disease in young adults. J Am Coll Cardiol. 2003; 41(4):529-31. DOI: 10.1016/s0735-1097(02)02861-9. View

16.

Tanis B, Bloemenkamp D, van den Bosch M, Kemmeren J, Algra A, van de Graaf Y . Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction. Br J Haematol. 2003; 122(3):471-8. DOI: 10.1046/j.1365-2141.2003.04454.x. View

17.

Miller M . Niacin as a component of combination therapy for dyslipidemia. Mayo Clin Proc. 2003; 78(6):735-42. DOI: 10.4065/78.6.735. View

18.

Malmberg K, Bavenholm P, Hamsten A . Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol. 1994; 24(3):592-9. DOI: 10.1016/0735-1097(94)90002-7. View

19.

Jouhikainen T, Stephansson E . Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus. 1994; 3(3):167-72. DOI: 10.1177/096120339400300307. View

20.

Fitzgerald J . The downside of isoniazid chemoprophylaxis. Lancet. 1995; 345(8947):404. DOI: 10.1016/s0140-6736(95)90397-6. View